DUXAP10 and metastatic malignant neoplasm in the lymph nodes: In addition, DUXAP10 overexpression was positively correlated with the adverse clinicopathological features and aggressive outcomes of several cancer types, including tumor size, TNM staging, histological grading, lymph node metastasis, and survival rates.